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OBJECTIVES: This study was conducted to clarify the rate of late diagnosis of HIV infection and to identify
relationships between the reasons for HIV testing and a late diagnosis.
METHODS: This retrospective cohort study was conducted among HIV-positive patients at the Jikei University
Hospital between 2001 and 2014. Patient characteristics from medical records, including age, sex, sexuality, the
reason for HIV testing and the number of CD4-positive lymphocytes at HIV diagnosis, were assessed.
RESULTS: A total of 459 patients (men, n=437; 95.2%) were included in this study and the median age at HIV
diagnosis was 36 years (range, 18–71 years). Late (CD4 cell counto350/mm3) and very late (CD4 cell counto200/mm3)
diagnoses were observed in 61.4% (282/459) and 36.6% (168/459) of patients, respectively. The most common
reason for HIV diagnosis was voluntary testing (38.6%, 177/459 patients), followed by AIDS-defining illness (18.3%,
84/459 patients). Multivariate analysis revealed a significant association of voluntary HIV testing with non-late and
non-very-late diagnoses and there was a high proportion of AIDS-defining illness in the late and very late diagnosis
groups compared with other groups. Men who have sex with men was a relative factor for non-late diagnosis,
whereas nonspecific abnormal blood test results, such as hypergammaglobulinemia and thrombocytopenia, were risk
factors for very late diagnosis.
CONCLUSIONS: Voluntary HIV testing should be encouraged and physicians should screen all patients who have
symptoms or signs and particularly hypergammaglobulinemia and thrombocytopenia, that may nonspecifically
indicate HIV infection.
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’ INTRODUCTION
With the development of antiretroviral therapy (ART), the
mortality andmorbidity associated with HIV have decreased (1).
In particular, Lohse et al. demonstrated an estimated median
survival of 435 years for a young HIV-positive individual (2).
Previous studies have also shown that survival improved with
early initiation of ART (3,4) and that ART initiation at CD4
countso500/mm3 improved the course of HIV infection (5).
In contrast, late diagnosis and delayed treatment of HIV
infection contribute to the development of opportunistic
infections, such as pneumocystis pneumonia and cytomega-
lovirus infection and increase hospitalization and mortality
risks (6-8). Moreover, reduction of HIV viral load by early
initiation of ART decreases the transmission rate of HIV
infection (9). Therefore, a World Health Organization guide-
line strongly recommends ART initiation for HIV patients
when CD4 counts are o500/mm3.
Timely initiation of ART requires an early diagnosis of HIV
infection, which can also contribute to reducing the prevalence
of high-risk sexual behavior conducive to HIV transmission
(10). Thus, early diagnosis of HIV infection is crucial to improve
patient survival and decrease the transmission rate. Although
various organizations recommend HIV testing for early
diagnosis, many patients are only diagnosed with HIV infection
when they develop AIDS-defined illness. An annual report
showed that more than 1,000 people have been newly diag-
nosed with HIV infection in Japan since 2007 and that 24,561
patients had been diagnosed with HIV infection by 2014. In
2014, 29.4% (455/1,546 patients with newly diagnosed HIV
infection) of patients were diagnosed with HIV infection upon
presenting with an AIDS-defining illness (http://api-net.jfap.
or.jp/status/2014/14nenpo/h26gaiyo.pdf). The rate of late
diagnosis of HIV infection differs among various countries.
Hall et al. demonstrated that the highest percentage of peopleDOI: 10.6061/clinics/2016(02)04
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diagnosed with late-stage disease was among people in the
United States (28.7%), followed by Australia (18.8%), France
(15.3%), Italy (14.5%) and Canada (8.8%) (11). In the present
study, we evaluated the reasons for HIV testing and their
relationships with a late diagnosis of HIV infection.
’ MATERIALS AND METHODS
Study population
The present study was conducted at a 1,075-bed hospital in
Tokyo, Japan, affiliated with the Jikei University School of
Medicine, which is one of the AIDS treatment core hospitals.
The study included adult patients with HIV infection who
visited the hospital between January 2001 and December 2014.
Study design
A retrospective cohort study was conducted to investigate
the reasons for HIV testing and their relationships with a late
diagnosis of HIV infection. Patient characteristics, such as
age, sex, sexuality, the reason for HIV testing and the CD4-
positive lymphocyte count at HIV infection diagnosis, were
assessed from the patients’ medical records at the hospital.
The reasons for HIV testing were classified into the follow-
ing six categories: AIDS-defining illness, sexually transmitted
infection (STI), nonspecific symptoms, nonspecific abnormal
blood test results, routine testing and voluntary testing.
Patients with AIDS-defining illness were those diagnosed
with at least one of the diseases listed by the Centers for
Disease Control and Prevention. Moreover, genital herpes
was considered an AIDS-defining illness, regardless of
whether it was the first or a repeated episode. STIs included
syphilis, amebic disease, hepatitis B, urethritis and condy-
loma acuminatum. Nonspecific symptoms were defined as
those that were not associated with an AIDS-defining illness
or STI. Routine testing included examination before a
medical procedure, such as blood donation, hospitalization,
or an operation. The date of the positive HIV test was the
earliest date of a documented positive anti-HIV antibody test
from a laboratory report at our hospital or another medical
institute, including other hospitals, clinics and healthcare
centers. Late diagnosis and very late diagnosis were defined
as CD4-positive T lymphocyte counts o350 cells/mm3 and
o200 cells/mm3, respectively, at the time of the initially
positive HIV test (12). We excluded patients with hemophilia
because we could not determine when they were infected
through blood products. Furthermore, patients for whom the
reason for HIV testing, the CD4 count and an accurate age at
the time of HIV diagnosis could not be confirmed were
excluded from this study (Figure 1).
Statistical analyses
The chi-square test or Fisher’s exact test was used to
compare categorical variables. The Mann-Whitney U test
was used to compare continuous variables. To determine
relative factors for late and very late diagnosis, a multiple
logistic regression model was used to control for potential
confounding variables. We present the results of the logistic
regression analysis as an adjusted odds ratio (AOR) with a
95% confidence interval (CI). P values were two-tailed and
statistical significance was set at po0.05. These statistical
analyses were conducted using SPSS version 19 (IBM Japan
Ltd).
Ethics
We could not obtain informed consent from the patients
because the present study was retrospective cohort study.
Therefore, we posted an announcement about this study.
This study does not present data that identify the patients
and was approved (approval no. 26-184 (7689)) by the institu-
tional ethics committee of the Jikei University Hospital.
’ RESULTS
Patient characteristics
A total of 540 patients infected with HIV visited our hospi-
tal during the investigation period. Among these patients,
81 were excluded from this investigation; 4 of these patients
had hemophilia and we could not confirm the reason for HIV
540 patients visited our hospital 
459 patients included
81 patients excluded
4 hemophilia
23 unconfirmed reasons for HIV testing
44 unconfirmed CD4 counts at HIV diagnosis
10 unconfirmed accurate age at HIV diagnosis
Non-late diagnosis
n = 177
Late diagnosis
n = 282
Non-very-late diagnosis
n = 291
Very late diagnosis
n = 168
Figure 1 - Chart of the inclusion and exclusion criteria in this study.
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testing for 23 patients, CD4 counts for 44 patients, or an
accurate age at the time of HIV diagnosis for 10 patients.
Therefore, in total, 459 patients met the inclusion criteria of
this study (Figure 1). HIV diagnosis occurred between 1996
and 2014 for all subjects, of whom 437 (95.2%) were men and
the median age was 36 (range, 18–71). Of the 437 male
subjects, 359 patients (82.2%) were men who have sex with
men (MSM) (Table 1). The median CD4 count at diagnosis
was 283/mm3 (range, 4–1443 mm3). A total of 282 patients
(61.4%) and 168 patients (36.6%) of the 459 subjects were
categorized as having a late or very late diagnosis, respec-
tively, and their rates remained approximately the same
during the study period (Figure 2).
Reasons for HIV testing
As shown in Table 1, the most common reason for HIV
testing was voluntary testing (38.6%, 177/459), followed by
AIDS-defining illness (18.3%, 84/459 patients). Among AIDS-
defining illnesses, Pneumocystis jirovecii pneumonia (PCP) was
the most common (59.5%, 50/84 patients) disease associated
with HIV infection, followed by Kaposi’s sarcoma (8.3%, 7/84
patients). Other patients were found to have HIV infection
due to the following AIDS-defining illnesses: candidiasis of
the esophagus, 3 patients; cryptococcal meningitis, 2; cryptos-
poridiosis, 1; cytomegalovirus infection, 4; HIV-related ence-
phalopathy, 3; herpes simplex, 3; pulmonary tuberculosis, 3;
lymphoma, 4; progressive multifocal leukoencephalopathy, 1;
and toxoplasmosis of the brain, 1. Two patients with multiple
AIDS-defining illnesses underwent HIV testing because they
had PCP and esophageal candidiasis.
However, 53 of the 459 patients (11.5%) tested positive for
HIV when they were diagnosed with other STIs. The most
common STI was syphilis (37.7%, 20/53 patients), followed
by amebic disease, condyloma acuminatum and hepatitis B
(each 18.9%, 10/53 patients). Of the 2 patients with urethritis,
one had urethritis caused by Neisseria gonorrhoeae infection
and the other had non-gonococcal and non-chlamydial
urethritis. A patient with multiple STIs was tested for HIV
because he had a past history of hepatitis B and syphilis.
In total, 95 patients (20.7%) were diagnosed with HIV
infection as one of the differential diagnoses for nonspecific
symptoms or nonspecific abnormal blood test results not
classified as definitive for an AIDS-defining illness or STIs.
Among 80 patients who had nonspecific symptoms, 11
(13.8%) were tested for the anti-HIV-1 antibody due to fever
without any symptoms. The most common nonspecific
symptom other than fever was skin lesions (26.3%, 21/80
patients), including nonspecific skin eruption, 11 patients;
herpes zoster, 6; molluscum contagiosum, 2; erythema
multiforme, 1; and scabies, 1. Lymphadenopathy was also
a common symptom leading to HIV testing (12.5%, 10/81
patients), including cervical lymphadenopathy in 8 patients,
generalized lymphadenopathy in 1 patient, and inguinal
lymphadenopathy in 1 patient. Two patients were tested for
HIV when they had other infectious diseases; one patient
had nonrecurrent bacterial pneumonia and the other had
candidemia because of a catheter-related bloodstream infec-
tion. Five patients had multiple symptoms when they were
diagnosed, including lymphadenopathy and skin rash (n=3),
oral candidiasis and lymphadenopathy (n=1) and oral
candidiasis and skin rash (n=1). Eleven patients, including
those who had multiple symptoms, were tested for HIV
because of oral candidiasis. Among these 11 patients with
oral candidiasis, 11 patients (100%) were diagnosed with
HIV infection as a late diagnosis and 9 patients (81.8%)
received a very late diagnosis.
Fifteen patients were tested for anti-HIV antibody to more
closely examine their abnormal blood test results. The most
common abnormal result was hypergammaglobulinemia
(46.7%, 7/15 patients), followed by thrombocytopenia
(26.7%, 4/15 patients), pancytopenia (13.3%, 2/15 patients)
and hemophagocytosis (6.7%, 1/15 patients). One patient was
tested for HIV because he had hypergammaglobulinemia and
Table 1 - Characteristics of patients with HIV infection.
Total Late
diagnosis
Non-late
diagnosis
p-value Very late
diagnosis
Non-very-late
diagnosis
p-value
n=459 n=282 n=177 n=168 n=291
n (%) n (%) n (%) n (%) n (%)
Male gender 437 (95.2) 267 (94.7) 170 (96.0) 0.505 159 (94.6) 278 (94.9) 0.667
MSM 359 (82.2) 207 (77.5) 152 (89.4) 0.002 121 (76.1) 238 (85.0) 0.015
Age (median and range) 36 (18–71) 37 (20–70) 33 (18–71) 0.001 39 (20–68) 34 (18–71) o0.001
The reason for HIV testing
AIDS-defining illness 84 (18.3) 80 (28.4) 4 (2.3) o 0.001 71 (42.3) 13 (4.5) o0.001
Sexually transmitted infection 53 (11.5) 28 (9.9) 25 (14.1) 0.171 12 (7.1) 41 (14.1) 0.025
Nonspecific symptom 80 (17.4) 51 (18.1) 29 (16.4) 0.640 34 (20.2) 46 (15.8) 0.228
Nonspecific abnormal result 15 (3.3) 13 (4.6) 2 (1.1) 0.041 11 (6.5) 4 (1.4) 0.003
Routine testing 50 (10.9) 36 (12.8) 14 (7.9) 0.104 14 (8.3) 36 (12.4) 0.181
Voluntary testing 177 (38.6) 74 (26.2) 103 (58.2) o 0.001 26 (15.5) 151 (51.9) o0.001
(year)
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Figure 2 - Proportions of late and very late diagnoses in this study.
The rates of the two diagnoses were similar during the study period.
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thrombocytopenia. All 8 patients with hypergammaglobuline-
mia and 5 of 7 patients (71.4%) with thrombocytopenia were
categorized as having a late diagnosis. Moreover, 7 of 8 patients
(87.5%) hypergammaglobulinemia and 4 of 7 patients (57.1%)
with thrombocytopenia received a very late diagnosis.
In addition, 50 patients were diagnosed with HIV infection
by routine testing. The most common reason for routine
testing was evaluation prior to a medical procedure (72.0%,
36/50 patients), including an operation (26), endoscopy (5),
hospitalization (2), fertility treatment (2), or a clinical trial (1).
Additionally, 12 patients (24.0%) were found to be HIV
positive on testing prior to blood donation and two patients
were diagnosed as HIV positive during prenatal care.
Relationships between late and very late diagnosis
and the reason for HIV testing
As shown in Table 1, in univariate analysis, patients in the
late diagnosis and very late diagnosis groups were sig-
nificantly older than those in the other groups. In addition,
AIDS-defining illness and nonspecific abnormal blood test
results were significantly more common as reasons for HIV
testing in the late and very late diagnosis groups than in the
other groups, whereas MSM and voluntary testing were
significantly less common reasons. In addition, STI was a
factor associated with very late diagnosis. Multivariate analysis
using the logistic regression model revealed independent
predictive factors for late diagnosis, which included AIDS-
defining illness (AOR=11.410; 95% CI=3.998–32.563; po0.001),
whereas the rates of MSM and voluntary testing in non-late
diagnosis were significantly higher than those in late diagnosis
(AOR=0.488; 95% CI=0.287–0.831; p=0.008 and AOR=0.418;
95% CI=0.274–0.638; po0.001, respectively) (Table 2a). In
contrast, AIDS-defining illness and nonspecific abnormal blood
test results were found to be independent relative factors for
very late diagnosis (AOR=11.196; 95% CI=5.747–21.814;
po0.001 and AOR=5.637; 95% CI=1.723–18.443; p=0.004,
respectively), whereas voluntary testing was significantly less
frequent among patients with very late diagnosis in the logistic
regression analysis (AOR=0.353; 95% CI=0.210–0.593; po0.001)
(Table 2b).
’ DISCUSSION
In Japan, people can choose to undergo HIV testing at any
medical facility, including healthcare centers, clinics and
hospitals. In addition, several of these facilities provide
voluntary counseling and testing for HIV that are free and
anonymous. However, after identification of HIV infection,
most HIV patients have to transfer to an AIDS treatment core
hospital, which can treat patients with HIV infection or
opportunistic infections. Not all of these AIDS treatment core
hospitals have all medical care equipment for specific
situations, such as deliveriesy, pediatric care or tuberculosis
treatment. Therefore, these patients have to transfer to other
AIDS treatment core hospitals that have adequate facilities.
Patients with HIV infection are usually treated with ART
based on the Japanese guideline, which is similar to other
guidelines, such as United States Department of Health and
Human Services guideline. Indeed, for asymptomatic HIV
patients, the timing of ART initiation depends on the CD4
count, with the cut-off being less than 200/mL until 2006, less
than 350/mL from 2006–2013 and less than 500/mL since
2013. HIV patients can receive medical care at public
expense; the expense that the patient pays depends on his
or her income, with patients responsible for paying 0–10% of
the cost (less than 20,000 yen) of medical practice, including
examination and ART. Therefore, we do not believe that cost
causes hesitation to undergo HIV testing in Japan.
Most previous studies have defined CD4 cell counts
o200 cells/mm3 as indicative of late HIV diagnosis.
However, Kitahata et al. showed that the mortality rate in
patients starting ART at CD4 counts o350 cells/mm3 is
significantly higher than that in patients starting ART at
CD4 counts of 350–500 cells/mm3 (3). Consequently, current
guidelines strongly recommend starting ART at CD4 counts
o500 cells/mm3. The European Late Presenter Consensus
Working Group defined late presentation as CD4-positive
T lymphocytes o350 cells/mm3 or as presentation with
an AIDS-defining illness, regardless of the CD4 cell count
and defined presentation with advanced HIV disease as
o200 cells/mm3 or presentation with AIDS-defining illness,
regardless of the CD4 cell count (13). In the present study,
we defined late diagnosis as a CD4-positive T lymphocyte
count o350 cells/mm3 and very late diagnosis as a count
o200 cells/mm3 at diagnosis, excluding AIDS-defining illness,
regardless of the CD4 cell count. This was a similar approach to
that reported in another study (12) because we included AIDS-
defining illness as one of the reasons for HIV testing in the
current study.
Other studies demonstrated that the rate of very late
diagnosis was 8.8–43% (7,11,12,14) and differed among
countries. In our study, we demonstrated that the rate of
very late diagnosis was 36.6%, which was similar to results
from Canada (39%) and Italy (39%) (7). In contrast, the rate of
late diagnosis has been reported as 51.3–63.5% (12,14,15),
which is similar to our result, or 61.4%. Girardi et al.
demonstrated that MSM was the factor responsible for the
reduced prevalence of late diagnosis (7). In our study, we found
that that MSM was a relatively associated factor for non-late
and non-very-late diagnosis; however, this finding for non-
very-late diagnosis was not supported in the multivariate
analysis. These results suggest that MSM was a factor
promoting HIV testing for both patients and physicians.
In our study, 80 of 459 patients (17.4%) were diagnosed with
HIV infection because they had nonspecific symptoms. Com-
mon symptoms in patients with primary HIV infection included
pharyngitis, lymphadenopathy and skin eruptions (14). Certain
patients with these symptoms were diagnosed with HIV
infection in the acute phase, although we could not determine
the accurate rate of primary HIV infection in our patients.
Table 2a - Relative factors for late diagnosis in the logistic
regression analysis.
Adjusted odds ratio 95% CI p-value
MSM 0.488 0.287–0.831 0.008
AIDS-defining illness 11.410 3.998–32.563 o0.001
Voluntary testing 0.418 0.274–0.638 o0.001
Table 2b - Relative factors for very late diagnosis in the logistic
regression analysis.
Adjusted
odds ratio
95% CI p-value
AIDS-defining illness 11.196 5.747–21.814 o0.001
Voluntary testing 0.353 0.210–0.593 o0.001
Nonspecific abnormal result 5.637 1.723–18.443 0.004
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Eleven patients, including patients who had multiple symp-
toms, were diagnosed with HIV infection because of oral
candidiasis on testing. In this study, oral candidiasis was
classified as a nonspecific symptom because we aimed to
evaluate the symptom as a reason for HIV testing. However, all
patients and 9 of 11 patients were categorized as having a late or
very late diagnosis, respectively. Therefore, we infer that an
immunocompromised status should be suspected and that HIV
testing should be conducted immediately in these patients in the
absence of other risk factors, such as inhalational steroid use. In
addition, we determined that certain patients were found to be
HIV positive as part of the differential diagnosis of meningitis,
weight loss, or a fever of unknown origin. Wohlgemut et al.
demonstrated that CD4 counts in patients who were not
diagnosed at first presentation were frequently o 200/mm3
compared with the counts of those who were diagnosed at
first presentation (12). Thus, these results indicate that HIV
screening should be initiated without hesitation upon the
first suspicion of viral infection or symptoms unexplained by
other diseases.
In the present study, 15 patients were tested for anti-HIV
antibody to more closely examine their abnormal blood test
results. Because these abnormal results, including hemophago-
cytosis, improved after ART, we determined that the ab-
normal results were because of HIV infection. The incidence of
monoclonal gammopathy of undetermined significance (MGUS,
or benign monoclonal gammopathy) is 3–26% in HIV patients
(15), so certain patients with HIV infection have hypergamma-
globulinemia, although the causal mechanism of hypergamma-
globulinemia because of HIV infection remains unclear (16).
Here, we showed that 8 patients, including 1 patient who
had hypergammaglobulinemia and thrombocytopenia, were
diagnosed with HIV infection as a differential diagnosis of
hypergammaglobulinemia. However, thrombocytopenia is pre-
sent in 5–30% of HIV patients (17). Kaslow et al. demonstrated a
higher prevalence of thrombocytopenia in patients with CD4
countso200 cells/mm3 compared with those who had levels
4700 cells/mm3 (18). In the current study, 7 patients
underwent HIV testing during the differential diagnosis of
thrombocytopenia, including 2 patients with pancytopenia;
the CD4 counts in 4 of these 7 patients (57.1%) was o200
cells/mm3 at the time of diagnosing HIV infection. Although
we could not clarify the prevalence of hypergammaglobuli-
nemia and thrombocytopenia in all patients, these results
indicate that abnormal blood test results were significantly
associated with low CD4 counts.
The limitations of this study include the small study
sample and the retrospective nature. In addition, we did not
evaluate other factors that may affect HIV testing, including
the city where the patients lived, their occupation and their
family structure. Therefore, we could not determine whether
the prognosis was affected by the reasons for HIV diagnosis
and whether these results are applicable to other populations
as well. However, we showed that voluntary HIV testing
prevented late and very late diagnoses of HIV infection and that
nonspecific abnormal blood test results, such as hypergamma-
globulinemia and thrombocytopenia, were significantly asso-
ciated with low CD4 counts of o 200/mm3. Therefore, we
believe that voluntary HIV testing should be encouraged for
early diagnosis and that physicians should lower their
threshold for HIV screening to include all patients with
symptoms or signs that may indicate an HIV infection.
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